NCT00937937 2026-03-18Dinaciclib in Treating Patients With Stage IV MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting72 enrolled 14 charts
NCT01026324 2017-04-04Dinaciclib in Treating Patients With Stage III-IV MelanomaNational Cancer Institute (NCI)Phase 1/2 Terminated12 enrolled 9 charts